Clinical trial
A Single Site Safety and Tolerability Study of HBOC-201 in Trauma Subjects
NCT00301483 · Biopure Corporation, Industry · Unknown status
Key facts
| NCT number | NCT00301483 |
|---|---|
| Title | A Single Site Safety and Tolerability Study of HBOC-201 in Trauma Subjects |
| Official title | A Single-Center, Study to Evaluate the Safety and Tolerability of Hemoglobin-Based Oxygen Carrier-201 (HBOC 201) in Trauma Subjects. (Phase II - Safety and Tolerability) |
| Lead sponsor | Biopure Corporation, Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Wounds and Injuries |
| Intervention type | Drug, Other |
| Interventions | Hemoglobin-based oxygen carrier-201 (HBOC 201), Standard of Care |
| Enrollment | 53 |
| Start date | Jul 1, 2004 |
| Primary completion | Sep 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Mar 13, 2006 |
| Last update posted | Mar 6, 2008 |
| Countries | South Africa |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: